These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2403129)

  • 1. The use of serial CA 125 concentrations to monitor endometriosis in infertile women.
    Pittaway DE
    Am J Obstet Gynecol; 1990 Sep; 163(3):1032-5; discussion 1035-7. PubMed ID: 2403129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis.
    Pittaway DE; Rondinone D; Miller KA; Barnes K
    Fertil Steril; 1995 Aug; 64(2):321-4. PubMed ID: 7615110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA-125 in women with endometriosis.
    Pittaway DE
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):237-52. PubMed ID: 2664620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA-125 in women with endometriosis and chronic pelvic pain.
    Pittaway DE; Douglas JW
    Fertil Steril; 1989 Jan; 51(1):68-70. PubMed ID: 2910718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum CA-125 and CA-72 in predicting endometriosis in infertility patients.
    Molo MW; Kelly M; Radwanska E; Binor Z
    J Reprod Med; 1994 Dec; 39(12):964-6. PubMed ID: 7884754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Ca-125 concentrations in endometriosis.
    Fedele L; Arcaini L; Vercellini P; Marchini M; Baglioni A; Bianchi S
    Acta Eur Fertil; 1989; 20(3):137-9. PubMed ID: 2533779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of CA-125 in the diagnosis and management of endometriosis.
    Pittaway DE; Fayez JA
    Fertil Steril; 1986 Nov; 46(5):790-5. PubMed ID: 3465595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological aspects of endometriosis].
    Kuhn U
    Gynakologe; 1990 Jun; 23(3):135-9. PubMed ID: 2201598
    [No Abstract]   [Full Text] [Related]  

  • 9. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis.
    O'Shaughnessy A; Check JH; Nowroozi K; Lurie D
    Obstet Gynecol; 1993 Jan; 81(1):99-103. PubMed ID: 8416469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay of CA-125 in serum of patients with endometriosis: efficacy in diagnosis.
    Kang JO; Hudak WA; Keller N; Criswell BS
    Clin Chem; 1988 Oct; 34(10):1983-6. PubMed ID: 3168208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis.
    Koninckx PR; Riittinen L; Seppala M; Cornillie FJ
    Fertil Steril; 1992 Mar; 57(3):523-30. PubMed ID: 1531465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA 125 antigen levels and disease severity in patients with endometriosis.
    Moloney MD; Thornton JG; Cooper EH
    Obstet Gynecol; 1989 May; 73(5 Pt 1):767-9. PubMed ID: 2704505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis.
    Panidis D; Vlassis G; Matalliotakis J; Skiadopoulos S; Kalogeropoulos A
    J Endocrinol Invest; 1988 Dec; 11(11):801-4. PubMed ID: 3225401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
    Marana R; Muzii L; Muscatello P; Lanzone A; Caruso A; Dell'Acqua S; Mancuso S
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1016-9. PubMed ID: 2147564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 125 in the management of endometriosis.
    Koninckx PR; Muyldermans M; Meuleman C; Cornillie FJ
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):109-13. PubMed ID: 8365504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of basal menses CA-125 levels and 6 month pregnancy rates in women undergoing treatments for infertility without assisted reproductive methods.
    Check JH; Cohen R; Peymer M; Resnick M; Suryanarayan C
    Am J Reprod Immunol; 1997 Apr; 37(4):315-9. PubMed ID: 9161639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
    Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
    Sov Med; 1990; (6):26-9. PubMed ID: 2204116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy of endometriosis.
    Kennedy SH; Mojiminiyi OA; Soper ND; Shepstone BJ; Barlow DH
    Br J Obstet Gynaecol; 1990 Aug; 97(8):667-70. PubMed ID: 2400745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of CA19-9 for endometriosis].
    Watanabe J; Johboh T; Hata H; Kuramoto H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):155-61. PubMed ID: 2313144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of endometriosis.
    Ranney B
    Curr Opin Obstet Gynecol; 1989 Dec; 1(2):220-6. PubMed ID: 2491124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.